ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2021-47858

Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface.

Published Jan 21, 2026 · catalog updated Mar 5, 2026 · Genexis Platinum-4410

Last checked Nov 4, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2021-47858. EPSS is 0.28%. Act only if a listed version of Genexis Platinum-4410 is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.28%
Remediation
Vendor / distro source
Affected products
vendor Genexis Platinum-4410 Firmware 1.31A

Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface. Attackers can inject malicious scripts through the start source address field that will persist and trigger for privileged users when they access the security management page.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Genexis Platinum-4410 Firmware 1.31AFirmware 1.31A

How to fix CVE-2021-47858

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2021-47858. EPSS is 0.28%. Act only if a listed version of Genexis Platinum-4410 is installed.

Which versions are affected?

Compare what you have installed with Genexis Platinum-4410 Firmware 1.31A Firmware 1.31A. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.28%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jan 21, 2026 · EUVD

    Detected

    Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface. Attackers can inject malicious scripts through the start source address field that will persist and trigger for privileged users when they access the security management page.

  2. Mar 5, 2026 · EUVD

    Updated

    Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface. Attackers can inject malicious scripts through the start source address field that will persist and trigger for privileged users when they access the security management page.

Sources

  • CVE.orgVulnerability recordCVE-2021-47858

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2021-47858

    30-day exploitation probability 0.28%

    first.org
  • EUVDVulnerability recordEUVD-2026-3641

    Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface. Attackers can inject malicious scripts through the start source address field that will persist and trigger for privileged

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Nov 3, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgNov 4, 2026
  • FIRST EPSSNov 3, 2026
  • EUVDNov 2, 2026